Currently, no specific drugs for sepsis are available, and drotrecogin alfa (recombinant human activated protein C), the only approved drug for severe sepsis treatment, was also withdrawn because it did not significantly reduce mortality in patients with severe sepsis and septic shock in several multicenter clinical trials 12, 13. Here, PROC is linked to Sepsis.